| scholarly article | Q13442814 |
| P2093 | author name string | Archibald E Garrod | |
| P2860 | cites work | The Darkening in Colour of Certain Urines on Exposure to the Air | Q55709869 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | alkaptonuria | Q651680 |
| P304 | page(s) | 221-31 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Yale Journal of Biology and Medicine | Q15709982 |
| P1476 | title | The incidence of alkaptonuria: a study in chemical individuality. 1902 [classical article] | |
| P478 | volume | 75 |
| Q58569528 | "Precision psychiatry": A promising direction so far |
| Q64360808 | A case of 'blue skin' and 'dark urine' |
| Q104795294 | A cross-platform approach identifies genetic regulators of human metabolism and health |
| Q90970989 | A father's fight to help his sons - and fix clinical trials |
| Q28256903 | A neuroectodermal syndrome of dominant inheritance |
| Q89047436 | A proposed nosology of inborn errors of metabolism |
| Q36665096 | A public health genetic approach for schizophrenia |
| Q44291066 | A short history of genetic counseling |
| Q34192401 | A short history of human genetics in the USA |
| Q69205444 | Advances in the use of computerized gas chromatography-mass spectrometry and high-performance liquid chromatography with rapid scanning detection for clinical diagnosis |
| Q37934608 | Alkaptonuria in France: past experience and lessons for the future |
| Q41002537 | Alkaptonuria: A case report |
| Q43605047 | Alkaptonuria: a case report |
| Q48857522 | Alkaptonuria: such a long journey |
| Q50226081 | Alkaptonuric ochronosis: a clinical study from Ardabil, Iran. |
| Q39762361 | Alpha-1-antitrypsin deficiency: a biological enigma |
| Q48053275 | An explosion, a tsunami, a runaway train: half a century of genetics |
| Q37144360 | An overview of biochemical genetics |
| Q69446109 | An ultrastructural and light microscopic study of the synovium in ochronotic arthropathy |
| Q34196817 | An update on molecular genetics of Alkaptonuria (AKU). |
| Q33564599 | ApreciseKUre: an approach of Precision Medicine in a Rare Disease. |
| Q48266619 | Archibald E. Garrod: the father of precision medicine. |
| Q53066159 | Archibald Edward Garrod and alcaptonuria: "Inborn errors of metabolism" revisited. |
| Q40029014 | Biogenic Amines in Mental Illness |
| Q78529461 | CLINICAL AND GENETIC STUDIES OF SOME CAROTENOIDS OF THE HUMAN BLOOD SERUM |
| Q39061550 | Cartilage biomarkers in the osteoarthropathy of alkaptonuria reveal low turnover and accelerated ageing |
| Q27317126 | Characterising the spectrum of autosomal recessive hereditary hearing loss in Iran |
| Q28118834 | Characterization of a fungal maleylacetoacetate isomerase gene and identification of its human homologue |
| Q26742050 | Clinical Metabolomics: The New Metabolic Window for Inborn Errors of Metabolism Investigations in the Post-Genomic Era |
| Q73428918 | Clinical pharmacogenomics: applications in pharmaceutical R&D |
| Q36850258 | Cloning of the homogentisate 1,2-dioxygenase gene, the key enzyme of alkaptonuria in mouse |
| Q24538328 | Comparative genomics and gene expression analysis identifies BBS9, a new Bardet-Biedl syndrome gene |
| Q55689889 | Computational methods to work as first-pass filter in deleterious SNP analysis of alkaptonuria. |
| Q34366023 | Consanguinity and its relevance to clinical genetics. |
| Q34086825 | Consulting the source code: prospects for gene-based medical diagnostics |
| Q59063959 | Control of Evolution in Man |
| Q37149509 | Cultural differences define diagnosis and genomic medicine practice: implications for undiagnosed diseases program in China |
| Q37222110 | Cytogenetics and the evolution of medical genetics |
| Q36291100 | Defining and addressing the nutritional needs of populations |
| Q80997948 | Defining drug disposition determinants: a pharmacogenetic-pharmacokinetic strategy |
| Q28749694 | Developing products for personalized medicine: NIH Research Tools Policy applications |
| Q33746321 | Development of molecular genetics |
| Q40532191 | Developmental biology and the study of malformations |
| Q41883496 | Difficult epidural in a patient with undiagnosed alkaptonuria |
| Q28646221 | Directional dominance on stature and cognition in diverse human populations |
| Q36364455 | Drug metabolism and pharmacogenetics: the British contribution to fields of international significance |
| Q34169809 | Early 20th-century research at the interfaces of genetics, development, and evolution: reflections on progress and dead ends |
| Q98614822 | Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial |
| Q26768636 | Environmental Chemical Assessment in Clinical Practice: Unveiling the Elephant in the Room |
| Q57646291 | Epithelioid Hemangioendothelioma as a Model of YAP/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma |
| Q49344679 | From Mendel to Medical Genetics |
| Q34929772 | From bench to bedside: a diagnostics framework for pharmacogenetics research |
| Q30414051 | From chemistry of life to chemistry of disease: the rise of clinical biochemistry |
| Q28296732 | Garrod's Croonian Lectures (1908) and the charter 'Inborn Errors of Metabolism': albinism, alkaptonuria, cystinuria, and pentosuria at age 100 in 2008 |
| Q34281057 | Garrod's foresight; our hindsight |
| Q34407923 | Gene-environment interactions in human diseases |
| Q94312652 | Genetic determination of nutritional requirements |
| Q67321248 | Genetic individuality |
| Q44577854 | Genetic markers: how accurate can genetic data be? |
| Q38049040 | Genetic variation in metabolic phenotypes: study designs and applications |
| Q39977805 | Genetically Determined Polymorphisms of Erythrocyte Enzymes in Man |
| Q39886823 | Genetics and the Synthesis of Proteins |
| Q34458072 | Genetics of the Framingham Heart Study population |
| Q38645534 | Genomic Bayesian functional regression models with interactions for predicting wheat grain yield using hyper-spectral image data |
| Q35024668 | Genotype-environment interactions and their translational implications |
| Q74509684 | Growing older: the adult metabolic clinic |
| Q92667670 | Harveian Oration 2019: Prediction and prevention in the genomic era |
| Q28651651 | History and evolution of cytogenetics |
| Q37783248 | Homeosis and Beyond. What Is the Function of the Hox Genes? |
| Q90598914 | How science has shifted our sense of identity |
| Q58442100 | Human Genetics As a Bridging Science |
| Q69879181 | Human Polymorphism |
| Q26775894 | Human genetic basis of interindividual variability in the course of infection |
| Q38644665 | Human genetics in troubled times and places |
| Q35502573 | INHERITED METABOLIC DISORDERS: ERRORS OF PHENYLALANINE AND TYROSINE METABOLISM. |
| Q45764322 | Inborn Errors of Metabolism: the metabolome is our world. Presidential address for the 11th International Congress of Inborn Errors of Metabolism (ICIEM). |
| Q38167824 | Inborn errors of metabolism and expanded newborn screening: review and update |
| Q64881508 | Inborn errors of metabolism in the 21st century: past to present. |
| Q37199418 | Inborn errors of metabolism: challenges and management |
| Q82659965 | Inborn variation in metabolism |
| Q41205228 | Influence of pharmacogenetics on drug disposition and response |
| Q24595262 | Inherited metabolic disease in companion animals: searching for nature's mistakes |
| Q38373635 | Knowledge base and mini-expert platform for the diagnosis of inborn errors of metabolism |
| Q35209973 | Mathematical multi-locus approaches to localizing complex human trait genes |
| Q35901064 | Mechanotransduction Mechanisms for Intraventricular Diastolic Vortex Forces and Myocardial Deformations: Part 2. |
| Q47277590 | Medical histories |
| Q37384824 | Metabolomics: unraveling the chemical individuality of common human diseases |
| Q42277901 | Molecular Characterization of a Gene Encoding a Homogentisate Dioxygenase from Aspergillus nidulans and Identification of Its Human and Plant Homologues |
| Q33899907 | Multiple sclerosis, vitamin D, and HLA-DRB1*15. |
| Q53611451 | Mutation screening of the HGD gene identifies a novel alkaptonuria mutation with significant founder effect and high prevalence. |
| Q33694024 | Mutation spectrum of homogentisic acid oxidase (HGD) in alkaptonuria |
| Q50498994 | Non-syndromic hearing impairment: gene linkage and cloning. |
| Q42696162 | Nutrigenomics in the modern era. |
| Q39731754 | OCULAR FINDINGS IN A CASE OF HEREDITARY OCHRONOSIS |
| Q21260367 | On the ocular findings in ochronosis: a systematic review of literature |
| Q37938905 | Overview of pharmacogenetics |
| Q39550538 | Personalized medicine: will dentistry ride the wave or watch from the beach? |
| Q45076492 | Perspective on in vitro fertilization and embryo transfer. Stimulus for biomedical research in reproductive medicine |
| Q35889619 | Pharmacogenetics - five decades of therapeutic lessons from genetic diversity |
| Q35219458 | Pharmacogenomic technologies: a necessary "luxury" for better global public health? |
| Q40770658 | Prevalence of Childhood Blindness and Ocular Morbidity in a Rural Pediatric Population in Southern India: The Pavagada Pediatric Eye Disease Study-1. |
| Q36325835 | Progress in capillary electrophoresis of biomarkers and metabolites between 2002 and 2005. |
| Q36064087 | Sensorineural hearing loss in children. |
| Q57162795 | Shared Selective Pressures on Fungal and Human Metabolic Pathways Lead to Divergent yet Analogous Genetic Responses |
| Q38656373 | Single-Subject Studies in Translational Nutrition Research. |
| Q52458891 | Sir Archibald Garrod's Conception of Chemical Individuality: A Modern Appreciation |
| Q54878936 | Special feature on evolution and genetics in medicine. |
| Q37836674 | Statistical issues in quality control of proteomic analyses: good experimental design and planning |
| Q46841460 | Succinylcholine: still beautiful and mysterious after all these years |
| Q36795399 | The PAH gene, phenylketonuria, and a paradigm shift |
| Q38125937 | The application of next-generation sequencing in the autozygosity mapping of human recessive diseases |
| Q34804631 | The changing face of newborn screening: diagnosis of inborn errors of metabolism by tandem mass spectrometry |
| Q37975105 | The family history: the first genetic test, and still useful after all those years? |
| Q39476884 | The future direction of personalised nutrition: my diet, my phenotype, my genes |
| Q39918520 | The genetics of metabolic disorders |
| Q28118128 | The molecular basis of alkaptonuria |
| Q39499560 | The molecular genetics of human monogenic diseases |
| Q33560453 | The new field of 'precision psychiatry'. |
| Q44123124 | The rise and fall and (urgently needed) rebirth of metabolic medicine. Donough O'Brien Presidential Address Society for Inherited Metabolic Disorders, Asilomar, CA, 5 March 2002. |
| Q37817617 | The role of nutritional genomics in developing an optimal diet for humans |
| Q49835278 | The role of the clinician in the multi-omics era: are you ready? |
| Q46190142 | Three-generational alkaptonuria in a non-consanguineous family |
| Q46303809 | Towards Precision Medicine for Hypertension: A Review of Genomic, Epigenomic, and Microbiomic Effects on Blood Pressure in Experimental Rat Models and Humans. |
| Q91678345 | Understanding Structure and Function as a Model for 21st-Century Health Care |
| Q46163363 | Weighted likelihood inference of genomic autozygosity patterns in dense genotype data. |
| Q50679784 | William Bateson, the rediscoverer of Mendel. |
| Q38987961 | XERODERMA PIGMENTOSUM. A BRIEF REPORT ON ITS GENETIC LINKAGE WITH ABO BLOOD GROUPS IN THE UNITED ARAB REPUBLIC. |
| Q74310590 | [Alkaptonuria: a rare cause of urine discoloration. Report of a case in a newborn] |
Search more.